Literature DB >> 18454487

Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.

May-Jean King1, Paul Telfer, Heather MacKinnon, Lisa Langabeer, Corrina McMahon, Philip Darbyshire, Didier Dhermy.   

Abstract

BACKGROUND: Flow cytometric analysis of eosin-5-maleimide (EMA)-labeled red blood cells (RBCs) has been used as a screening test for the diagnosis of patients with hereditary spherocytosis (HS). We assessed the fluorescence profiles for patients having HS and hereditary pyropoikilocytosis (HPP) together with their red cell indices.
METHODS: Flow cytometry was used to analyze EMA-labeled RBCs. Membrane protein defects and spectrin variants were identified by SDS-polyacrylamide gel electrophoresis.
RESULTS: An overlay of single fluorescence peaks for normal individuals, and those with HS and HPP revealed a graded fluorescence intensity (normal > HS > HPP). The area under each peak defined a specific RBC subpopulation; namely, normal RBCs, spherocytes, and microspherocytes. HS RBCs having a gross reduction in band 3 or spectrin content gave fluorescence readings almost as low as those for HPP. Complex fluorescence profiles were obtained for isolated HS and HPP cases.
CONCLUSIONS: The mean cell volume is a useful discriminator for HS and HPP. We presented evidence that a mixed RBC population could occur in some HS and HPP patients, either in a transient manner or for a long-term period. A differential diagnostic scheme for detecting HPP and HS by flow cytometry is proposed. (c) 2008 Clinical Cytometry Society

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18454487     DOI: 10.1002/cyto.b.20413

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  18 in total

Review 1.  Abnormalities of the erythrocyte membrane.

Authors:  Patrick G Gallagher
Journal:  Pediatr Clin North Am       Date:  2013-10-15       Impact factor: 3.278

2.  Causes of hemolysis in neonates with extreme hyperbilirubinemia.

Authors:  R D Christensen; R H Nussenzveig; H M Yaish; E Henry; L D Eggert; A M Agarwal
Journal:  J Perinatol       Date:  2014-04-24       Impact factor: 2.521

3.  Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics.

Authors:  Paola Bianchi; Elisa Fermo; Cristina Vercellati; Anna P Marcello; Laura Porretti; Agostino Cortelezzi; Wilma Barcellini; Alberto Zanella
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

4.  Flow Cytometric Eosin-5'-Maleimide Test is a Sensitive Screen for Hereditary Spherocytosis.

Authors:  Preethi S Chari; Sujay Prasad
Journal:  Indian J Hematol Blood Transfus       Date:  2017-12-06       Impact factor: 0.900

5.  Evaluating eosin-5-maleimide binding as a diagnostic test for hereditary spherocytosis in newborn infants.

Authors:  R D Christensen; A M Agarwal; R H Nussenzveig; N Heikal; M A Liew; H M Yaish
Journal:  J Perinatol       Date:  2014-11-06       Impact factor: 2.521

Review 6.  New insights on hereditary erythrocyte membrane defects.

Authors:  Immacolata Andolfo; Roberta Russo; Antonella Gambale; Achille Iolascon
Journal:  Haematologica       Date:  2016-10-18       Impact factor: 9.941

7.  Diagnostic tool for red blood cell membrane disorders: Assessment of a new generation ektacytometer.

Authors:  Lydie Da Costa; Ludovic Suner; Julie Galimand; Amandine Bonnel; Tiffany Pascreau; Nathalie Couque; Odile Fenneteau; Narla Mohandas
Journal:  Blood Cells Mol Dis       Date:  2015-09-16       Impact factor: 3.039

Review 8.  Laboratory Approach to Hemolytic Anemia.

Authors:  Manu Jamwal; Prashant Sharma; Reena Das
Journal:  Indian J Pediatr       Date:  2019-12-10       Impact factor: 1.967

Review 9.  Old and new insights into the diagnosis of hereditary spherocytosis.

Authors:  Olga Ciepiela
Journal:  Ann Transl Med       Date:  2018-09

10.  Mean corpuscular volume of control red blood cells determines the interpretation of eosin-5'-maleimide (EMA) test result in infants aged less than 6 months.

Authors:  Olga Ciepiela; Anna Adamowicz-Salach; Weronika Bystrzycka; Jan Łukasik; Iwona Kotuła
Journal:  Ann Hematol       Date:  2015-04-25       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.